• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经内镜鼻窦手术诊断的伴有 V600E 突变的 Erdheim-Chester 病 1 例。

A case of Erdheim-Chester disease with the V600E mutation diagnosed via endoscopic sinus surgery.

机构信息

Department of General Medicine, Nagoya University Hospital, Nagoya, Japan.

Department of Otorhinolaryngology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

出版信息

Nagoya J Med Sci. 2023 Feb;85(1):150-156. doi: 10.18999/nagjms.85.1.150.

DOI:10.18999/nagjms.85.1.150
PMID:36923612
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10009614/
Abstract

Erdheim-Chester disease is characterized by the infiltration of foamy histiocytes in tissues. Lesional tissue biopsy is recommended to confirm diagnosis and establish the mutational status. A 52-year-old man presented to our hospital with hydronephrosis. Computed tomography showed enhancement of soft shadows around the left renal pelvis transition area and the aorta. He was treated with prednisolone 0.2 mg/kg for 1 year; however, no improvement was observed. Fluorodeoxyglucose-positron emission tomography/computed tomography revealed increased fluorodeoxyglucose uptake in various body parts, including the maxillary sinuses, indicative of Erdheim-Chester disease. He refused further examination, and the maxillary sinus lesions were treated with antibiotics and intranasal steroids, but no improvement was observed. Two years later, he underwent biopsy with endoscopic sinus surgery of the maxillary sinus, which showed the highest increase in fluorodeoxyglucose uptake on repeat fluorodeoxyglucose-positron emission tomography/computed tomography. Endoscopic findings showed only nonspecific inflammatory findings, but pathological findings revealed the proliferation of cells with abundant foamy cytoplasms. Sufficient tumor volume was available to perform PCR for V600E mutation analysis, which was positive and resulted in a diagnosis of Erdheim-Chester disease with the V600E mutation. This is the first case of a patient with Erdheim-Chester disease with the V600E mutation identified in a sinus lesion. Endoscopic sinus surgery biopsy of the paranasal sinuses was considered to contribute to the histological and genetic diagnosis of Erdheim-Chester disease, particularly following the notable increase in fluorodeoxyglucose uptake.

摘要

额狄氏-切斯特病的特征是组织中泡沫状组织细胞的浸润。建议进行病变组织活检以确认诊断并确定突变状态。一名 52 岁男性因肾积水就诊于我院。计算机断层扫描显示左肾盂过渡区和主动脉周围软组织阴影增强。他接受了泼尼松龙 0.2mg/kg 治疗 1 年,但未见改善。氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描显示氟脱氧葡萄糖摄取在包括上颌窦在内的多个身体部位增加,提示为额狄氏-切斯特病。他拒绝进一步检查,上颌窦病变采用抗生素和鼻内类固醇治疗,但未见改善。两年后,他接受了上颌窦内镜鼻窦手术活检,重复氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描显示氟脱氧葡萄糖摄取增加最高。内镜检查仅显示非特异性炎症表现,但病理检查显示大量泡沫细胞质的细胞增殖。有足够的肿瘤体积可进行 V600E 突变分析的 PCR,结果为阳性,诊断为伴有 V600E 突变的额狄氏-切斯特病。这是首例在鼻窦病变中发现伴有 V600E 突变的额狄氏-切斯特病患者。鼻旁窦的内镜鼻窦手术活检被认为有助于额狄氏-切斯特病的组织学和遗传学诊断,尤其是在氟脱氧葡萄糖摄取显著增加后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92da/10009614/7bebff18991d/2186-3326-85-0150-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92da/10009614/855762dd729c/2186-3326-85-0150-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92da/10009614/7bebff18991d/2186-3326-85-0150-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92da/10009614/855762dd729c/2186-3326-85-0150-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92da/10009614/7bebff18991d/2186-3326-85-0150-g002.jpg

相似文献

1
A case of Erdheim-Chester disease with the V600E mutation diagnosed via endoscopic sinus surgery.经内镜鼻窦手术诊断的伴有 V600E 突变的 Erdheim-Chester 病 1 例。
Nagoya J Med Sci. 2023 Feb;85(1):150-156. doi: 10.18999/nagjms.85.1.150.
2
Abdominal involvement in Erdheim-Chester disease (ECD): MRI and CT imaging findings and their association with BRAF mutation. Erdheim-Chester 病(ECD)的腹部受累:MRI 和 CT 影像学表现及其与 BRAF 突变的关系。
Eur Radiol. 2018 Sep;28(9):3751-3759. doi: 10.1007/s00330-018-5326-1. Epub 2018 Mar 19.
3
Erdheim-Chester disease with an 18F-fluorodeoxyglucose-avid breast mass and BRAF V600E mutation.伴 18F-氟脱氧葡萄糖摄取的乳腺肿块和 BRAF V600E 突变的 Erdheim-Chester 病。
Jpn J Radiol. 2014 May;32(5):282-7. doi: 10.1007/s11604-014-0295-z. Epub 2014 Feb 16.
4
Hypoalphalipoproteinemia and BRAF Mutation Are Major Predictors of Aortic Infiltration in the Erdheim-Chester Disease.低α脂蛋白血症和 BRAF 突变是 Erdheim-Chester 病主动脉浸润的主要预测因子。
Arterioscler Thromb Vasc Biol. 2018 Aug;38(8):1913-1925. doi: 10.1161/ATVBAHA.118.310803.
5
A case of Erdheim-Chester disease with spinal cord compression and sphenoid sinus involvement.一例伴有脊髓压迫和蝶窦受累的厄尔德海姆-切斯特病。
Neurochirurgie. 2018 Dec;64(6):439-441. doi: 10.1016/j.neuchi.2018.08.002. Epub 2018 Sep 28.
6
Erdheim-Chester disease involving the breast--a rare but important differential diagnosis.累及乳腺的 Erdheim-Chester 病——一种罕见但重要的鉴别诊断。
Hum Pathol. 2015 Jan;46(1):159-64. doi: 10.1016/j.humpath.2014.10.005. Epub 2014 Oct 18.
7
Evaluation of clinicopathologic characteristics and the BRAF V600E mutation in Erdheim-Chester disease among Chinese adults.中国成人Erdheim-Chester病的临床病理特征及BRAF V600E突变评估
Ann Hematol. 2016 Apr;95(5):745-50. doi: 10.1007/s00277-016-2606-1. Epub 2016 Feb 9.
8
Thoracic involvement in Erdheim-Chester disease: computed tomography imaging findings and their association with the BRAF mutation. Erdheim-Chester 病的胸部受累:计算机断层扫描成像表现及其与 BRAF 突变的关系。
Eur Radiol. 2018 Nov;28(11):4635-4642. doi: 10.1007/s00330-018-5421-3. Epub 2018 May 7.
9
BRAF V600E mutation in Juvenile Xanthogranuloma family neoplasms of the central nervous system (CNS-JXG): a revised diagnostic algorithm to include pediatric Erdheim-Chester disease.中枢神经系统(CNS-JXG)幼年黄色肉芽肿家族性肿瘤中的 BRAF V600E 突变:包括小儿神经鞘黏液瘤病在内的修订诊断算法。
Acta Neuropathol Commun. 2019 Nov 4;7(1):168. doi: 10.1186/s40478-019-0811-6.
10
Does the BRAF(V600E) mutation herald a new treatment era for Erdheim-Chester disease? A case-based review of a rare and difficult to diagnose disorder.BRAF(V600E)突变是否预示着 Erdheim-Chester 病的新治疗时代?基于病例对一种罕见且难以诊断的疾病的综述。
Intern Med J. 2015 Mar;45(3):348-51. doi: 10.1111/imj.12685.

引用本文的文献

1
Molecular Mutations in Histiocytosis: A Comprehensive Survey of Genetic Alterations.组织细胞增多症中的分子突变:基因改变的全面综述
Mol Biotechnol. 2025 Feb;67(2):438-455. doi: 10.1007/s12033-024-01072-2. Epub 2024 Feb 20.

本文引用的文献

1
Dramatic response to encorafenib in a patient with Erdheim-Chester disease harboring the BRAF mutation.一名患有携带BRAF突变的 Erdheim-Chester 病患者对恩考芬尼产生显著反应。
Am J Hematol. 2021 Aug 1;96(8):E295-E298. doi: 10.1002/ajh.26232. Epub 2021 May 26.
2
Erdheim-Chester disease: a rapidly evolving disease model.厄德海姆-切斯特病:一种快速演变的疾病模型。
Leukemia. 2020 Nov;34(11):2840-2857. doi: 10.1038/s41375-020-0944-4. Epub 2020 Jun 26.
3
Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era.
骨硬化性嗜酸性肉芽肿:分子时代下的评估、诊断和治疗的共识建议。
Blood. 2020 May 28;135(22):1929-1945. doi: 10.1182/blood.2019003507.
4
Erdheim-Chester disease.额颞叶痴呆。
Blood. 2020 Apr 16;135(16):1311-1318. doi: 10.1182/blood.2019002766.
5
A rare differential for sinusitis and visual loss.鼻窦炎与视力丧失的一种罕见鉴别诊断。
Ann R Coll Surg Engl. 2020 Feb;102(2):e42-e44. doi: 10.1308/rcsann.2019.0130. Epub 2019 Sep 20.
6
Percutaneous needle biopsy of retroperitoneal lesions: technical developments.腹膜后病变的经皮针吸活检:技术进展
Acta Biomed. 2019 Apr 24;90(5-S):62-67. doi: 10.23750/abm.v90i5-S.8331.
7
Comparison of diagnostic methods for the detection of a BRAF mutation in papillary thyroid cancer.甲状腺乳头状癌中BRAF突变检测诊断方法的比较
Oncol Lett. 2019 May;17(5):4661-4666. doi: 10.3892/ol.2019.10131. Epub 2019 Mar 8.
8
FDA Approval Summary: Vemurafenib for the Treatment of Patients with Erdheim-Chester Disease with the V600 Mutation.FDA 批准概要:威罗非尼治疗 V600 突变的 Erdheim-Chester 病患者。
Oncologist. 2018 Dec;23(12):1520-1524. doi: 10.1634/theoncologist.2018-0295. Epub 2018 Aug 17.
9
Vemurafenib for BRAF V600-Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis: Analysis of Data From the Histology-Independent, Phase 2, Open-label VE-BASKET Study.维莫非尼治疗 BRAF V600 突变型 Erdheim-Chester 病和朗格汉斯细胞组织细胞增生症:来自组织学独立、开放标签 VE-BASKET 研究的数据分析。
JAMA Oncol. 2018 Mar 1;4(3):384-388. doi: 10.1001/jamaoncol.2017.5029.
10
F-FDG PET/CT in Erdheim-Chester Disease: Imaging Findings and Potential BRAF Mutation Biomarker.FDG PET/CT 在 Erdheim-Chester 病中的应用:影像学表现与潜在 BRAF 基因突变生物标志物。
J Nucl Med. 2018 May;59(5):774-779. doi: 10.2967/jnumed.117.200741. Epub 2017 Nov 2.